News

Washington, D.C. (October 17, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released a staff report detailing efforts by the Trump Administration to compromise the scientific integrity of the Centers for Disease Control and Prevention’s (CDC) coronavirus response in an attempt to serve the former President’s political goals. This staff report is the third installment in a series of reports documenting the Select Subcommittee’s findings from its investigation into the Trump Administration’s rampant political interference with the federal public health response to the coronavirus pandemic.

Washington, D.C. (September 21, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released new evidence of dire conditions inside for‑profit nursing home chains during the early months of the pandemic, as well as documents that shed light on how convoluted corporate structures have been used by for-profit nursing home chains and may have helped these companies to obscure profits and avoid accountability. The new documents are being released in advance of today’s scheduled 2 p.m. ET hearing entitled “Examining Long-Term Care in America: The Impact of the Coronavirus in Nursing Homes.”

Washington, D.C. (September 21, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for a hearing on “Examining Long-Term Care in America: The Impact of the Coronavirus in Nursing Homes” with nursing home experts, a frontline worker, and a resident advocate.

Washington, D.C. (Sept. 9, 2022) — Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to Mr. Richard K. Delmar, Deputy Inspector General of the Department of the Treasury, requesting a thorough review of the federal funding Treasury disbursed to airlines to sustain their operations during the coronavirus pandemic, including whether any funds were used for buyouts or staff reductions.